Search for: "Daubert v. Merrell Dow Pharmaceuticals, Inc." Results 221 - 240 of 292
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
6 Dec 2016, 6:01 am by Anjelica Cappellino
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), which outlines a non-exhaustive list of factors for the courts to consider when determining the expert testimony admissibility. [read post]
13 Jul 2019, 8:53 am by Schachtman
Merrell Dow Pharms., Inc., 509 U.S. 579, 595 (1993). [8]  Bench Book at 10. [9]  Id. at 10. [10]  Id. at 10. [11] See State Justice Institute Act of 1984 (42 U.S.C. ch. 113, 42 U.S.C. [read post]
28 Feb 2018, 6:00 am by Victoria Negron
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993) to conclude whether the expert possesses the requisite level of expertise and whether the testimony is both relevant and reliable. [read post]
6 Dec 2016, 6:01 am by Anjelica Cappellino
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), which outlines a non-exhaustive list of factors for the courts to consider when determining the expert testimony admissibility. [read post]
21 Jun 2011, 5:00 am by Bexis
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), applies to class certifications. [read post]
12 Apr 2018, 6:00 am by Anjelica Cappellino
Merrell Dow Pharmaceuticals, Inc. 509 U.S. 579 (1993), which enumerates the factors a court should consider when admitting expert testimony, along with its progeny, also fails to address what exactly “reasonable degree of certainty” means. [read post]
18 Feb 2020, 5:00 am by Anjelica Cappellino
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993) or Frye v. [read post]
31 Oct 2019, 5:00 am by Anjelica Cappellino
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993) will consider a non-exhaustive list of factors such as the expert’s methodology and reliability. [read post]
5 Nov 2007, 12:58 pm
Merrell Dow Pharmaceuticals, Inc., 43 F.3d 1311, 1320 (9th Cir. 1995); DeLuca v. [read post]
14 May 2015, 2:15 pm by Maureen Johnston
Merrell Dow Pharmaceuticals and its progeny, permits a district court to require epidemiological evidence as a precondition for admissibility of a qualified expert's opinion that a toxic substance is capable of causing a particular disease. [read post]
5 Jan 2022, 4:33 am by Jon L. Gelman
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579, 113 S.Ct. 2786, 125 L.Ed.2d 469 (1993).Where does the universe of disability terminate? [read post]
22 Aug 2013, 1:57 pm by Stephen Gomez
The majority of states have adopted the Daubert standard, though several states refuse to explicitly adopt either Frye or Daubert, but choose to apply similar standards that acknowledge Daubert.[17] IV. [read post]
13 Sep 2019, 6:00 am by Guest Blogger
[vi]And then-Justice Rehnquist might have joined the majority in Washington v. [read post]